Procept BioRobotics Procept BioRobotics is a surgical robotics company that provides urologic care solutions. | ![]() Uromedica Uromedica is a company that develops implantable balloon therapy to treat male and female stress urinary incontinence. | ![]() Caldera Medical Caldera Medical is a women‘s health medical device company focused on minimally invasive applications. | ![]() AqueSys AqueSys is an ophthalmic company, which focuses on developing and commercializing implantable devices for treatment of glaucoma. | Gala Therapeutics Gala Therapeutics is a medical device company developing technologies for the treatment of pulmonary diseases. | |
Founding Date | Founding Date 2009 | Founding Date 1997 | Founding Date 2002 | Founding Date 2006 | Founding Date 2015 |
Type | Type Public | Type Private | Type Private | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations San Jose, US HQ | Locations Minneapolis, US HQ | Locations Westlake Village, US HQ Agoura Hills, US | Locations Irvine, US HQ | Locations San Carlos, US HQ |
Employees | Employees 6682% increase | Employees 303% decrease | Employees 1131% decrease | Employees 420% decrease | Employees 7 |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 1.5m (over 18 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 42.5m (over 6 years ago) |
Total funding raised | Total funding raised $ 328m | Total funding raised $ 1.5m | Total funding raised N/A | Total funding raised $ 101.5m | Total funding raised $ 70m |

Uromedica is a company that develops implantable balloon therapy to treat male and female stress urinary incontinence.
View company
Caldera Medical is a women‘s health medical device company focused on minimally invasive applications.
View company
AqueSys is an ophthalmic company, which focuses on developing and commercializing implantable devices for treatment of glaucoma.
View companyGala Therapeutics is a medical device company developing technologies for the treatment of pulmonary diseases.
View company